CAPROCK Group, Inc.
- SEC CIK
- 0001610769
- Latest filing
- Jul 27, 2026
MRNA holding history
Moderna, Inc. in every 13F filed by CAPROCK Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRNA overviewAll 13F holders of MRNAFull Q2 2026 holdings
- Shares (Q2 2026)
- 7,765
- Value
- $543.8K
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 7,765 | $543.8K | <0.1% | −1,181−13.2% | Reduced | Holders |
| Q1 2026 | 8,946 | $454.5K | <0.1% | +8,946 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −13,884−100.0% | Sold out | Holders |
| Q3 2025 | 13,884 | $334.5K | <0.1% | – | No prior filing | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −4,886−100.0% | Sold out | Holders |
| Q4 2024 | 4,886 | $203.2K | <0.1% | +4,886 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −5,122−100.0% | Sold out | Holders |
| Q2 2024 | 5,122 | $608.2K | <0.1% | +2,040+66.2% | Added | Holders |
| Q1 2024 | 3,082 | $328.4K | <0.1% | +621+25.2% | Added | Holders |
| Q4 2023 | 2,461 | $244.7K | <0.1% | −42−1.7% | Reduced | Holders |
| Q3 2023 | 2,503 | $258.5K | <0.1% | +2,503 | New | Holders |